您现在的位置:
药品资讯网
>>
专业资料首页 >> FDA批准药品数据库 >>
NORITATE--FDA批准药品数据库
NORITATE--FDA批准药品数据库
- 发布时间:2004-10-25 来源:本站整理
-
【通用名称】
NORITATE
【剂 型】
CREAM; TOPICAL
【规 格】
1%

【活性成份】
METRONIDAZOLE
【基本药物】
是
〖资料类型〗
Label
〖文档日期〗
2003-04-04 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2004-07-04 00:00:00
〖DocTypeDesc〗
Package Change
〖下载地址〗
〖资料类型〗
Label
〖文档日期〗
2003-04-04 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2003-04-04 00:00:00
〖DocTypeDesc〗
Labeling Revision
〖下载地址〗
〖资料类型〗
Label
〖文档日期〗
2003-04-04 00:00:00
〖ActionType〗
AP

〖ActionDate〗
1997-09-26 00:00:00
〖DocTypeDesc〗
Approval
〖下载地址〗
〖资料类型〗
Letter
〖文档日期〗
2003-04-18 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2004-07-04 00:00:00
〖DocTypeDesc〗
Package Change
〖下载地址〗
〖资料类型〗
Letter
〖文档日期〗
2003-04-18 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2003-04-04 00:00:00
〖DocTypeDesc〗
Labeling Revision
〖下载地址〗
〖资料类型〗
Letter
〖文档日期〗
2003-04-18 00:00:00
〖ActionType〗
AP

〖ActionDate〗
1997-09-26 00:00:00
〖DocTypeDesc〗
Approval
〖下载地址〗
〖资料类型〗
Review
〖文档日期〗
2003-08-07 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2004-07-04 00:00:00
〖DocTypeDesc〗
Package Change
〖下载地址〗
〖资料类型〗
Review
〖文档日期〗
2003-08-07 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2003-04-04 00:00:00
〖DocTypeDesc〗
Labeling Revision
〖下载地址〗
〖资料类型〗
Review
〖文档日期〗
2003-08-07 00:00:00
〖ActionType〗
AP

〖ActionDate〗
1997-09-26 00:00:00
〖DocTypeDesc〗
Approval
〖下载地址〗
〖资料类型〗
Letter
〖文档日期〗
2004-07-06 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2004-07-04 00:00:00
〖DocTypeDesc〗
Package Change
〖下载地址〗
〖资料类型〗
Letter
〖文档日期〗
2004-07-06 00:00:00
〖ActionType〗
AP

〖ActionDate〗
2003-04-04 00:00:00
〖DocTypeDesc〗
Labeling Revision
〖下载地址〗
〖资料类型〗
Letter
〖文档日期〗
2004-07-06 00:00:00
〖ActionType〗
AP

〖ActionDate〗
1997-09-26 00:00:00
〖DocTypeDesc〗
Approval
〖下载地址〗
赞助商链接
FDA批准药品数据库
- HYDROFLUMETHIAZIDE,TABLET; ORAL,50MG
- CHLORPROPAMIDE,TABLET; ORAL,100MG
- AMITRIPTYLINE HYDROCHLORIDE,TABLET; ORAL,10MG
- AMITRIPTYLINE HYDROCHLORIDE,TABLET; ORAL,25MG
- AMITRIPTYLINE HYDROCHLORIDE,TABLET; ORAL,50MG
- AMITRIPTYLINE HYDROCHLORIDE,TABLET; ORAL,75MG
- AMITRIPTYLINE HYDROCHLORIDE,TABLET; ORAL,100MG
- ALLERFED,TABLET; ORAL,60MG;2.5MG
- HYDROXYZINE HYDROCHLORIDE,INJECTABLE; INJECTION,25
- PHENYLBUTAZONE,TABLET; ORAL,100MG
- PROMETHAZINE W/ DEXTROMETHORPHAN,SYRUP; ORAL,15MG/
- PREDNISONE,TABLET; ORAL,5MG
- PREDNISONE,TABLET; ORAL,10MG
- PREDNISONE,TABLET; ORAL,20MG
- PHERAZINE VC,SYRUP; ORAL,5MG/5ML;6.25MG/5ML
- THIORIDAZINE HYDROCHLORIDE,TABLET; ORAL,150MG
- PHERAZINE VC W/ CODEINE,SYRUP; ORAL,10MG/5ML;5MG/5
- NORCET,TABLET; ORAL,500MG;5MG
- THIORIDAZINE HYDROCHLORIDE,TABLET; ORAL,200MG
- ENLON,INJECTABLE; INJECTION,10MG/ML
推荐专业资料
- IUPAC Name: N-(2,4-difluorophenyl)-2-[(5R)-2-(2,3-
- ZINC03378819
- IUPAC Name: (2-amino-2-oxoethyl),(E)-2-cyano-3-[1-
- ZINC03287737,T0520-2344,
- ZINC03295526
- IUPAC Name: (2-ethylamino-2-oxoethyl),(Z)-3-[5-chl
- ZINC03306959
- ZINC03378080
- T5215905
- ZINC03378120,T0519-7371,
- ZINC03326085
- T5325006
- ZINC03354746
- ZINC03306699,T0515-7805,
- IUPAC Name: 4-(azepan-1-ylsulfonyl)-N-[(1R)-1-(1H-
- ZINC03301012
- ZINC03342000,T5281034,
- IUPAC Name: (2R)-2-[[5-[(2-fluorophenoxy)methyl]-4
- ZINC03297205
- T0517-5001